Stefania Lamartina

Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors

Philip Jones, Sergio Altamura, Julia K. Boueres et al. · Journal of Medicinal Chemistry · 2009 · 305 citations · Full text

Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector

Alessandra Recchia, Robin J. Parks, Stefania Lamartina et al. · Proceedings of the National Academy of Sciences · 1999 · 164 citations · Full text

Stringent Control of Gene Expression <i>In Vivo</i> by Using Novel Doxycycline-Dependent <i>Trans</i> -Activators

Stefania Lamartina, Giuseppe Roscilli, C. Daniela Rinaudo et al. · Human Gene Therapy · 2002 · 92 citations

Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates

Stefania Lamartina, Luisa Silvi, Giuseppe Roscilli et al. · Molecular Therapy · 2003 · 85 citations · Full text

Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system

Valentina Salucci, Alessia Scarito, Luigi Aurisicchio et al. · Gene Therapy · 2002 · 70 citations

Viral Replication, Repressor System, Natural Sciences +7